A new optimized bowl-shaped mono-core surface plasmon resonance (SPR) based cancer sensor is proposed. By considering the refractive index (RI) of each individual cancer contaminated cell with respect to their normal cell, some major optical parameters variation are observed. Moreover, the cancerous cell concentration is considered at 80% in liquid form and the detection method is finite element method (FEM) with 2100390 mesh elements. The variation of spectrum shift is obtained by plasmonic band gap between the silica and cancer cell part which is separated by a thin (35 nm) titanium film coating. The proposed sensor depicts a high birefringence of 0.04 with a maximum coupling length of 66 $\mu$ m. However, the proposed structure provides an optimum wavelength sensitivity level between about 10000 nm/RIU and 17500 nm/RIU with a resolution of the sensor between 1.5 $\times$ 10 $^{-2}$ RIU and 9.33 $\times$ 10 $^{-3}$ RIU. Also, the transmittance variance of the cancerous cell ranges from almost 3300 dB/RIU to 6100 dB/RIU and the amplitude sensitivity ranges nearly between -340 RIU $^{-1}$ and -420 RIU $^{-1}$ with the maximum detection limit of 0.025. Besides, the overall sensitivity performance is measured with respect to their normal cells which can be better than any other prior structures that have already proposed.
Photonic sensing is a novel technology and accurate measurement for biosensing applications. The present work proposes a defective one-dimensional photonic crystal (1D-PC) based on Si/SiO 2 -layers with a central liquid-filled defect layer as a blood sugar concentration biosensor in the visible region. The transmission spectrum is calculated numerically by using the transfer matrix method. The thickness of the defect layer and incident angle are optimized to achieve the best performance of the sensor. The results show that the localization of defect mode shifts to a longer wavelength with increasing the defect layer thickness. In addition to increasing the incident angle from θ0 = 0° to θ0 = 90°, the defect peak was shifted towards the short wavelength region. The optimized value of our structure demonstrates high sensitivity for the blood sugar ( S = 1100 nm/RIU) in the range of concentration 0–500 mg dl −1 , more enhancement of the quality factor (3.539 × 10 6 ) and very low limit of detection (8.8 × 10 −9 RIU) are achieved. Our results indicate that the proposed structure has higher performance as a blood sugar sensor than many previously reported data. Besides, the simplicity of the proposed structure makes it favorable to the industrial design using inexpensive and massive product nanofabrication techniques.
A plasmonic material-coated circular-shaped photonic crystal fiber (C-PCF) sensor based on surface plasmon resonance (SPR) is proposed to explore the optical guiding performance of the refractive index (RI) sensing at 1.7–3.7 μm. A twin resonance coupling profile is observed by selectively infiltrating liquid using finite element method (FEM). A nano-ring gold layer with a magnesium fluoride (MgF) coating and fused silica are used as plasmonic and base material, respectively, that help to achieve maximum sensing performance. RI analytes are highly sensitive to SPR and are injected into the outmost air holes of the cladding. The highest sensitivity of 27,958.49 nm/RIU, birefringence of 3.9 × , resolution of 3.70094 × RIU, and transmittance dip of −34 dB are achieved. The proposed work is a purely numerical simulation with proper optimization. The value of optimization has been referred to with an experimental tolerance value, but at the same time it has been ensured that it is not fabricated and tested. In summary, the explored C-PCF can widely be eligible for RI-based sensing applications for its excellent performance, which makes it a solid candidate for next generation biosensing applications.
This paper reports about the outcomes from an investigation carried out on tunable biosensor for detection using infrared in the range of 1.5 µm and 1.65 µm. The biosensor is made of phase change material formed by different alloy combinations, Ge2Sb2Te5 (GST). The nature of GST allows for the material to change phase with changes in temperature, giving the tunable sensing property for biosensing application. Sensor built with amorphous GST (aGST) and crystalline GST (cGST) in different design structures were tested on different concentrations of biomolecules: hemoglobin (10 g/l, 20 g/l, 30 g/l and 40 g/l); and urine (0–1.5 mg/dL, 2.5 mg/dL, 5 mg/dL and 10 mg/dL). The tunable response observed from the tests demonstrates the potential application of the materials in the design of switching and sensing systems.